Alfredo Pascual headshot
EMAIL: [email protected]
PHONE: 720.213.5971

Alfredo Pascual

Based in Germany, Alfredo specializes in international cannabis markets and regulations, drawing upon his extensive academic background in business and public policy. He founded Transnational Cannabis, a consultancy firm that focused on cannabis regulatory frameworks in Europe and Latin America. Previously, he did business development for ICC Labs with a primary focus on developing expansion opportunities internationally.


Majority of German parliament favors recreational cannabis reform, but change neither sure nor imminent

One of the German government coalition parties clarified its stance on recreational marijuana last week in favor of decriminalizing possession and allowing pilot programs involving the legal distribution of adult-use cannabis. With the Social Democratic Party of Germany (SPD)’s new position, a majority of the members of the German parliament represent a political party in […]

Read More

German insurer paints picture of nation’s growing medical cannabis industry

Applications for reimbursement of medical cannabis expenses by Germany’s second-largest health insurer doubled from 2017 to 2019, signaling robust growth in the use of the drug. Flower remained one of the most prescribed cannabis products, according to data provided in a new release by German insurer Barmer. Assuming trends witnessed by Barmer are representative of the overall […]

Read More

Switzerland’s recreational cannabis pilot program will allow only organic products

Switzerland’s lower house health commission cleared the way for a limited pilot program to allow the legal production and distribution of recreational marijuana. The move is not intended to be a first step toward full legalization. The general recreational cannabis prohibition will continue. The results of the experiment will be used for future evidence-based cannabis policy, although […]

Read More

Aurora to resume medical cannabis sales in Germany

Alberta, Canada-based Aurora Cannabis said Monday that it obtained the necessary permits to resume sales of medical marijuana in Germany. In November, Marijuana Business Daily reported that the company’s products were not available in Germany until further notice. According to Aurora, pharmacies can now start fulfilling orders from “inventory currently held in Germany.” Germany, the largest […]

Read More

Medical cannabis flower imported into Germany doubles again in 2019, confirming strong growth

Germany imported 6,714 kilograms (14,802 pounds) of medical cannabis flower, primarily for pharmacy dispensing in 2019, according to fresh data from the nation’s medical regulatory agency. That’s more than double the total for 2018, when about 3 metric tons were imported. Data from the Federal Institute for Drugs and Medical Devices (BfArM) confirms the strong […]

Read More

German pharmacies have new pharmaceutical CBD supplier

The medical cannabidiol market is becoming more competitive in Germany, as 2020 kicks off with one new CBD option that pharmacists can dispense to patients. A Cologne, Germany-based distributor of medical cannabis started offering pure CBD in kits with which pharmacists can compound preparations according to a doctor’s prescription. The kits allow pharmacists to prepare […]

Read More

European Commission falls short on WHO cannabis recommendations, experts say

The European Commission’s proposal that European Union-member countries support three of the six World Health Organization (WHO) cannabis scheduling recommendations does not merit much celebration from the cannabis industry, according to international drug policy experts. “The only good point in the draft’s common position is that the EU should support the deletion of cannabis from Schedule IV, but […]

Read More

Product supply interruptions hit German medical cannabis market, but government dismisses risk of shortages

Supply disruptions are rippling through Germany’s growing medical cannabis market, but the country’s federal government says there are no signs at the moment of widespread product shortages. In response to a recent parliamentary inquiry, the government noted that pharmacies that sell medical cannabis have access to a variety of distributors beyond some companies whose products […]

Read More

European Commission proposes unified EU vote on WHO cannabis scheduling recommendations

In advance of the March session of the United Nations Commission on Narcotic Drugs (CND), the European Union’s executive branch has proposed that EU member nations vote in favor of three of the six World Health Organization (WHO) cannabis scheduling recommendations. The European Commission “Proposal for a Council Decision” is meaningful because – if adopted by […]

Read More

Avicanna signs medical cannabis supply deal with Canada’s Shoppers Drug Mart

Toronto-based Avicanna – which has cultivation operations in Colombia – on Friday announced an agreement with Shoppers Drug Mart to supply Canada’s largest pharmacy chain with medical cannabis. However, the products – at least initially – won’t be shipped from Colombia. Avicanna will have one or more Canadian producers manufacture them, which will then be sold online […]

Read More

New medical cannabis sales opportunities in Peru face downward price pressure after winning company’s very low bid

The price offered by the winner of the first bidding process to supply medical cannabis in Peru came in well below that of other applicants, setting a precedent for the market’s future and possibly limiting the revenue opportunities for other suppliers. According to government documentation obtained by Marijuana Business Daily, Oregon-based Anden Naturals won the government’s supply […]

Read More